In this video blog Ron Shapiro, MD discusses an immunosuppression strategy for renal transplantation in extrarenal transplant recipients with loss of native kidneys to calcineurin inhibitor toxicity. Medscape Transplantation
Even the most up-to-date drugs do not prevent progression of chronic hypertensive kidney disease in most African Americans, according to a study in the Archives of Internal Medicine for April 28. Reuters Health Information
An immunosuppressive regimen of alemtuzumab preconditioning with tacrolimus monotherapy and subsequent spaced weaning may be effective in pediatric renal transplant recipients. American Journal of Transplantation
